Compared with control mice, mice treated with solenopsin analogues for 28 days showed significant decreases in acanthosis and hyperkeratosis, decreases in TLR4 expression and IL-22, and increases in IL-12 [64]. The gene discussed is IL22; the disease is Hyperkeratosis.